Title: Congenital Myelodysplastic Syndrome in a Newborn with Germline JAK2 Variant Treated with Liposomal Cytarabine-Daunorubicin and Allogeneic Hematopoietic Stem Cell TransplantAuthors:Kristin E. Zorn1*, Kathleen M. Bone2, Maria E. Hintzke2, Amy Moskop1, Zachary Graff1Affiliations:1. Division of Hematology/Oncology/Blood and Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin and Children’s Wisconsin, Milwaukee, WI2. Department of Pathology, Medical College of Wisconsin, Milwaukee, WI* Current Affiliation –Division of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MOCorresponding author: Kristin E. ZornWashington University School of MedicineDivision of Pediatric Hematology/Oncology660 S. Euclid AveSt. Louis, MO 63110Phone: (314)-454-6018Fax: (844)-621-4392Email: zorn@wustl.eduWord count: 840Figures: 2Running Title: Congenital Myelodysplastic SyndromeKeywords: Myelodysplastic Syndrome, AML, JAK2Abbreviations: